Avastin Shows No Benefit Against Early Stage Colon Cancer (HealthDay)
HealthDay - SATURDAY, May 30 (HealthDay News) — The cancer drug Avastin,
widely used for lung, breast and metastatic colorectal cancers, appears
ineffective for patients with early stage colon cancer, a result the
trial’s lead author called “disappointing.”
This entry was posted
on Sunday, May 31st, 2009 at 1:29 am and is filed under Health.
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.